Skip to content

Clinical trials

Phase 1/2 Stomach Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Phase: Phase 1/2 Country / region: France Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20141
20151
20163
20182
20202
20212
20221
20233
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting6
Recruiting5
Completed4
Terminated3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Merus B.V.2
Amgen1
Basilea Pharmaceutica1
Bolt Biotherapeutics, Inc.1
EMD Serono Research & Development Institute, Inc.1
Institut Bergonié1
Marengo Therapeutics, Inc.1
Nektar Therapeutics1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms19
Carcinoma, Non-Small-Cell Lung10
Colorectal Neoplasms8
Squamous Cell Carcinoma of Head and Neck5
Biliary Tract Neoplasms4
Endometrial Neoplasms4
Esophageal Neoplasms4
Breast Neoplasms3
Gastrointestinal Neoplasms3
Head and Neck Neoplasms3

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.